A/APublished research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Response to ketogenic dietary therapies in epilepsy compared to the general population. (GWAS Catalog, Epilepsia 2018, PMID:30009487)
A/GPublished research associates this genotype (one copy of the reported risk allele) with an intermediate association with Response to ketogenic dietary therapies in epilepsy. (GWAS Catalog, Epilepsia 2018, PMID:30009487)
G/GPublished research associates this genotype with typical/baseline likelihood of Response to ketogenic dietary therapies in epilepsy — no copies of the reported risk allele. (GWAS Catalog, Epilepsia 2018, PMID:30009487)
rs12204701 is a single position in the genome, in or near the CDYL gene. Published research associates it with response to ketogenic dietary therapies in epilepsy. A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.
What conditions is rs12204701 linked to?
On MyGeneLog this position is linked to Epilepsy. The research behind each link, and its sources, are set out on that condition page.
Does having rs12204701 mean I will get this?
No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.
Where does the information about rs12204701 come from?
GWAS Catalog, Epilepsia 2018, PMID:30009487. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.